Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3903 ARTÍCULOS , VIENDO DEL 631 AL 645

Evaluation of the valvular and biventricular functions in Parkinson patients using ergotamine-derived dopamine agonist: an observational study

Ozer N, Yorgun H, Canpolat U, Elibol B.

Anadolu Kardiyol Derg. 2014 Mar;14(2):121-7. doi: 10.5152/akd.2014.4834. Epub 2014 Jan 14.

Gene therapy and cell reprogramming for the aging brain: achievements and promise

Pardo J, Morel GR, Astiz M, Schwerdt JI, León ML, Rodríguez SS, Hereñú CB, Goya RG.

Curr Gene Ther. 2014 Feb;14(1):24-34. doi: 10.2174/1566523214666140120121733.

Abnormal metabolic network activity in REM sleep behavior disorder

Holtbernd F, Gagnon JF, Postuma RB, Ma Y, Tang CC, Feigin A, Dhawan V, Vendette M, Soucy JP, Eidelberg D, Montplaisir J.

Neurology. 2014 Feb 18;82(7):620-7. doi: 10.1212/WNL.0000000000000130. Epub 2014 Jan 22.

Global developmental delay, progressive relapsing-remitting parkinsonism, and spinal syrinx in a child with SOX6 mutation

Scott O, Pugh J, Kiddoo D, Sonnenberg LK, Bamforth S, Goez HR.

J Child Neurol. 2014 Nov;29(11):NP164-7. doi: 10.1177/0883073813514134. Epub 2014 Jan 21.

Factors influencing obstacle crossing performance in patients with Parkinson's disease

Liao YY, Yang YR, Wu YR, Wang RY.

PLoS One. 2014 Jan 13;9(1):e84245. doi: 10.1371/journal.pone.0084245. eCollection 2014.

Associations between severity of motor function and nonmotor symptoms in Parkinson's disease: a post hoc analysis of the RECOVER Study

Swick TJ, Friedman JH, Chaudhuri KR, Surmann E, Boroojerdi B, Moran K, Ghys L, Trenkwalder C.

Eur Neurol. 2014;71(3-4):140-7. doi: 10.1159/000355019. Epub 2014 Jan 21.

A comparative kinematic analysis of cyclical bending in patients with early stages of Parkinson's disease and in patients with essential tremor

Kurgansky M, Frolov A, Ioffe M, Karabanov A, Chernikova L.

Motor Control. 2014 Oct;18(4):331-46. doi: 10.1123/mc.2012-0096. Epub 2014 Jan 21.

Dietary herb extract rikkunshi-to ameliorates gastroparesis in Parkinson's disease: a pilot study

Doi H, Sakakibara R, Sato M, Hirai S, Masaka T, Kishi M, Tsuyusaki Y, Tateno A, Tateno F, Takahashi O, Ogata T.

Eur Neurol. 2014;71(3-4):193-5. doi: 10.1159/000355608. Epub 2014 Jan 21.

Genetics of Parkinson's disease: alpha-synuclein and other insights from Greece

Proukakis C.

Eur J Neurol. 2014 Jul;21(7):946-7. doi: 10.1111/ene.12357. Epub 2014 Jan 25.

Comparison of dopamine transporter decline in a patient with Parkinson's disease and normal aging effect

Ishibashi K, Oda K, Ishiwata K, Ishii K.

J Neurol Sci. 2014 Apr 15;339(1-2):207-9. doi: 10.1016/j.jns.2014.01.015. Epub 2014 Jan 15.

Psychiatric diseases predated the occurrence of Parkinson disease: a retrospective cohort study

Lin HL, Lin HC, Chen YH.

Ann Epidemiol. 2014 Mar;24(3):206-13. doi: 10.1016/j.annepidem.2013.12.010. Epub 2014 Jan 1.

Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease

Overk CR, Masliah E.

Biochem Pharmacol. 2014 Apr 15;88(4):508-16. doi: 10.1016/j.bcp.2014.01.015. Epub 2014 Jan 21.

The role of D2-autoreceptors in regulating dopamine neuron activity and transmission

Ford CP.

Neuroscience. 2014 Dec 12;282:13-22. doi: 10.1016/j.neuroscience.2014.01.025. Epub 2014 Jan 23.

Grey matter changes in cognitively impaired Parkinson's disease patients

Rektorova I, Biundo R, Marecek R, Weis L, Aarsland D, Antonini A.

PLoS One. 2014 Jan 21;9(1):e85595. doi: 10.1371/journal.pone.0085595. eCollection 2014.

Retinal nerve fiber layer thickness changes in Parkinson disease: a meta-analysis

Yu JG, Feng YF, Xiang Y, Huang JH, Savini G, Parisi V, Yang WJ, Fu XA.

PLoS One. 2014 Jan 21;9(1):e85718. doi: 10.1371/journal.pone.0085718. eCollection 2014.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias